Design Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Design Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
  • Design Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 4.06 %, a 4.24% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 4.06 -0.18 -4.24% Jun 30, 2024
Q1 2024 4.51 +0.76 +20.3% Mar 31, 2024
Q4 2023 4.57 +1.23 +36.7% Dec 31, 2023
Q3 2023 4.54 +1.69 +59.3% Sep 30, 2023
Q2 2023 4.24 +1.81 +74.5% Jun 30, 2023
Q1 2023 3.75 +1.85 +97.7% Mar 31, 2023
Q4 2022 3.35 +1.79 +115% Dec 31, 2022
Q3 2022 2.85 +1.28 +81.6% Sep 30, 2022
Q2 2022 2.43 Jun 30, 2022
Q1 2022 1.89 Mar 31, 2022
Q4 2021 1.55 Dec 31, 2021
Q3 2021 1.57 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.